Research progress and risk management of post transplantation diabetes mellitus in renal transplantation recipients

doi:10.3877/cma.j.issn.1674-3903.2020.03.014

Abstract

Abstract:

Post transplantation diabetes mellitus (PTDM) is a serious metabolic complication after renal transplantation. Currently, PTDM is diagnosed according to the diagnostic criteria of type Ⅱ diabetes mellitus published by American Diabetes Association in 2018. Age, body mass index, race, metabolic syndrome, HCV serologically positive, TCF7L2 genovariation, hypomagnesemia, and the use of immunosuppressive agents all affect the occurrence of PTDM in renal transplantation recipients. The PTDM in renal transplantation recipients has always been the focus of prevention and treatment of postoperative complications. Mastering the risk factors of PTDM and the management of PTDM can help reduce the incidence of PTDM and improve the quality of life of recipients. This paper reviews the possible risk factors and management methods of PTDM.

Key words: Renal transplantation, Post transplantation diabetes mellitus, Risk factors, Risk evaluation, Immunosuppression

Hongmei Yu, Zhuowen Hao, Gongpeng Sun, Zhipeng Fan, Li Dong, Qifa Ye. Research progress and risk management of post transplantation diabetes mellitus in renal transplantation recipients[J]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(03): 196-200.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2020.03.014

https://zhyzzz.cma-cmc.com.cn/EN/Y2020/V14/I03/196

References 42

1	Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003[J]. Transplantation, 2003, 75(10 Suppl):SS3-S24.
2	中华医学会器官移植学分会. 中国移植后糖尿病诊疗技术规范(2019版)[J]. 器官移植，2019, 10(1): 1-9.
3	Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions[J]. Am J Transplant, 2014, 14(9): 1992-2000.
4	American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl 1): S73-S85.
5	Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U．S. wait-listed and transplanted renal allograft recipients[J]. Am J Transplant, 2003, 3(5): 590-598.
6	Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transplant, 2007, 7(6): 1506-1514.
7	Peracha J, Nath J, Ready A, et al. Risk of post-transplantation diabetes mellitus is greater in South Asian versus Caucasian kidney allograft recipients[J]. Transpl Int, 2016, 29(6): 727-739.
8	Dienemann T, Fujii N, Li Y, et al. Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study[J]. Transpl Int, 2016, 29(9): 1017-1028.
9	Shivaswamy V, Boerner B, Larsen J, et al. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes[J]. Endocr Rev, 2016, 37(1): 37-61.
10	Yu H, Kim H, Baek CH, et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea-a retrospective single center study[J]. BMC Nephrol, 2016, 17(1):106.
11	Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation[J]. Transplantation, 2006, 82(12): 1673-1676.
12	Gürsoy M, Güvener N, Köksal R, et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients[J]. Transplant Proc, 2000, 32(3): 561-562.
13	Chakkera HA, Hanson RL, Raza SM, et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation[J]. Transplant Proc, 2009, 41(10): 4172-4177
14	Bayer ND, Cochetti PT, Anil Kumar MS, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation[J]. Transplantation, 2010, 90(8): 861-866.
15	Hap K, Madziarska K, Zmonarski S, et al. Pretransplantation oral glucose tolerance test can prevent posttransplant diabetes mellitus after renal transplantation: preliminary study[J]. Transplant Proc, 2018, 50(6):1776-1780.
16	Han E, Kim MS, Kim YS, et al. Risk assessment and management of post-transplant diabetes mellitus[J]. Metabolism, 2016, 65(10): 1559-1569.
17	Vatankhah Yazdi K, Kalantar SM, Houshmand M, et al. SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are associated with type 2 diabetes mellitus in iranian patients[J]. Diabetes Metab Syndr Obes, 2020, 13: 897-906.
18	Voight BF, Scott LJ, Steinthorsdottir V, et al. Type 2 diabetes susceptibility loci identified through large-scale association analysis[J]. Nat Genet, 2010, 42(7): 579-589.
19	Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes[J]. J Clin Invest, 2007, 117(8): 2155-2163.
20	Laurenti MC, Dalla Man C, Varghese RT, et al. Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans[J]. JCI Insight, 2020, 5(7): 136136.
21	Ye Y, Barghouth M, Luan C, et al. The TCF7L2-dependent high-voltage activated calcium channel subunit α2δ-1 controls calcium signaling in rodent pancreatic beta-cells[J]. Mol Cell Endocrinol, 2020, 502: 110673.
22	Ghisdal L, Baron C, Le Meur Y, et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation[J]. J Am Soc Nephrol, 2009, 20(11): 2459-2467.
23	Kang ES, Kim MS, Kim CH, et al. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea[J]. Transplantation, 2009, 88(5): 693-698.
24	Lv C, Chen M, Xu M, et al. Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate[J]. PLoS One, 2014, 9(6): e99406.
25	Van Laecke S, Desideri F, Geerts A, et al. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation[J]. Liver Transpl, 2010, 16(11):1278-1287.
26	Haller MC, Royuela A, Nagler EV, et al. Steroid avoidance or withdrawal for kidney transplant recipients[J]. Cochrane Database Syst Rev, 2016, (8): CD005632.
27	Mourad G, Glyda M, Albano L, et al. Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: advance, a randomized controlled trial[J]. Transplantation, 2017, 101(8):1924-1934.
28	Song JL, Li M, Yan LN, et al. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation[J]. Int J Surg, 2018, 51: 17-23.
29	Wissing KM, Abramowicz D, Weekers L, et al. Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation[J]. Am J Transplant, 2018, 18(7): 1726-1734.
30	Garnier AS, Duveau A, Planchais M, et al. Serum magnesium after kidney transplantation: a systematic review[J]. Nutrients, 2018, 10(6): E729.
31	Flechner SM, Glyda M, Cockfield S, et al. The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients[J]. Am J Transplant, 2011, 11(8): 1633-1644.
32	Gatault P, Bertrand D, Büchler M, et al. Eight-year results of the spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation[J]. Transpl Int, 2016, 29(1): 41-50.
33	Bergrem HA, Valderhaug TG, Hartmann A, et al. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy[J]. Clin J Am Soc Nephrol, 2010, 5(4): 616-622.
34	American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2010, 33(Suppl 1):S62-S69.
35	Pimentel AL, Cavagnolli G, Camargo JL, et al. Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis[J]. Nephrol Dial Transplant, 2017, 32(3): 565-572.
36	Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions[J]. Am J Transplant, 2014, 14(9): 1992-2000.
37	Valderhaug TG, Jenssen T, Hartmann A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation[J]. Transplantation, 2009, 88(3): 429-434.
38	Boerner BP, Shivaswamy V, Wolatz E, et al. Post-transplant diabetes: diagnosis and management[J]. Minerva Endocrinol, 2018, 43(2): 198-211.
39	Md Dom ZI, Coller JK, Carroll RP, et al. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients[J]. Br J Clin Pharmacol, 2018, 84(10): 2433-2442.
40	Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation[J]. Clin Transplant, 2005, 19(3): 291-298.
41	Haidinger M, Antlanger M, Kopecky C, et al. Post-transplantation diabetes mellitus: evaluation of treatment strategies[J]. Clin Transplant, 2015, 29(5):415-424.
42	Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention[J]. Acta Diabetologica, 2018, 55(8): 763-779.

[1]	Huanyan Liu, Yang Hua, Lingyun Jia, Xinyu Zhao, Beibei Liu. Lumen structure and hemodynamic characteristics of occluded internal carotid artery [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 809-815.
[2]	Yanbo Ma, Yang Hua, Guimei Liu, Xiufeng Meng, Liping Cui. Risk factors for carotid atherosclerotic lesions in middle adults [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 822-826.
[3]	Yingxiong Huang, Zi Ye, Peng Jiang, Hong Zhan, Chen Yao, Ji Cui. Clinical risk factors for transmural intestinal necrosis in acute mesenteric venous thrombosis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 413-421.
[4]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[5]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[6]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[7]	Xian Mo, Chuang Yang. Meta-analysis of risk factors for portal vein thrombosis in patients with cirrhosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 678-683.
[8]	Yonghuan Mao, Hanwen Tong, Ji Miao, Xingzhou Wang, Xiaofei Shen, Chunzhao Yu. Analysis of risk factors and prediction model of parastomal hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 682-687.
[9]	Chao Hou, Meichen Pan, Wenming Wu, Xingguang Huang, Xiang Li, Lingxue Cheng, Yuxuan Zhu, Wenbo Li. Risk factors of esophageal stricture after endoscopic submucosal dissection for early esophageal carcinoma and intraepithelial neoplasia [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 383-387.
[10]	Wen Zhang, Mudan Song, Xueting Deng, Yun Zhang. Enhanced nutritional support assisted with octreotide in the treatment of esophageal and gastric variceal bleeding in patients with liver cirrhosis and risk factors for rebleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 456-460.
[11]	Menggui Lu, Bin Huang, Qiulin Li, Yuanmei He. Risk factors for multiple organ dysfunction syndrome in patients with bee sting injury [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 1010-1015.
[12]	Da Li, Daya Zhang, Runxiang Chen, Xiaodong Zhang, Shimei Huang, Chen Chen, fan Zeng, Shiju Chen, Feihu Bai. Epidemiological characteristics and risk factors of Helicobacter pylori infection in Dongfang city of Hainan province [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 858-864.
[13]	Ke Meng, Yan Li, Jingshuang Yan, Bin Yan. Risk factors for prolonged gastric transit time in capsule endoscopy [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 671-675.
[14]	Yanli Yang, Yu Chen, Ruochen Zhao, Wei Du, Haijuan Ma, Ke Xu, Liyun Zhang. Bloodstream infection in patients with systemic lupus erythematosus: risk factors and bacteriological analysis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 694-699.
[15]	Peipei Sun, Erming Zhang, Yanwei Shi, Chunyan Zhao, Pingping Song, Shuo Zhang, Ke Zhang, Yujiao Zhou, Can Zhao, Wei Yan, Rongju Wu, Liping Song, Weian Guo, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang. Prevalence and risk factors of chronic obstructive pulmonary disease in residents aged 40 years and above in Shijingshan district of Beijing [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 711-719.

Please choose a citation manager

Content to export